![Matthew Klein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Klein
Algemeen Directeur bij PTC THERAPEUTICS, INC.
Vermogen: 31 M $ op 30-11-2025
Profiel
Matthew B. Klein currently works at PTC Therapeutics, Inc., as President, Chief Executive Officer & Director from 2023, Clearpoint Neuro, Inc., as Independent Director from 2020, PTC Therapeutics International Ltd., as Director, and Stanford University, as Clinical Associate Professor.
Dr. Klein also formerly worked at the University of Washington, as Chairman-Restorative Burn Surgery, BioElectron Technology Corp., as Director from 2019 to 2020, and Edison Pharmaceuticals, Inc., as Chief Medical Officer & Senior Vice President.
Dr. Klein received his undergraduate degree from the University of Pennsylvania, doctorate degree from Yale University, and graduate degree from UW School of Public Health.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-12-2025 | 349.964 ( 0,44% ) | 30 M $ | 30-11-2025 | |
| 22-05-2025 | 50.518 ( 0,18% ) | 730 490 $ | 30-11-2025 |
Laatste nieuws over Matthew Klein
Actieve functies van Matthew Klein
| Bedrijven | Functie | Begin |
|---|---|---|
| CLEARPOINT NEURO, INC. | Directeur/Bestuurslid | 16-04-2020 |
| PTC THERAPEUTICS, INC. | Algemeen Directeur | 22-03-2023 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
PTC Therapeutics International Ltd. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew Klein
| Bedrijven | Functie | Einde |
|---|---|---|
BioElectron Technology Corp.
 BioElectron Technology Corp. Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | Algemeen Directeur | 01-01-2019 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Edison Pharmaceuticals, Inc.
 Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Matthew Klein
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
PTC Therapeutics, Inc.
 PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clearpoint Neuro, Inc.
 Clearpoint Neuro, Inc. Develops and markets bio technology and surgical products | |
PTC Therapeutics International Ltd. | |
BioElectron Technology Corp.
BioElectron Technology Corp. Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | |
UW School of Public Health
 UW School of Public Health Functions as a College/University |
